DPYD Test
R4 650
Tests for DPYD gene variants linked to severe reactions to fluoropyrimidine chemotherapy. Helps guide safer dosing and drug selection before treatment starts.
DPYD Test
A panel that examines SNPs in the DPYD gene, which processes chemotherapy agents in the fluoropyrimidine class. Certain changes in this gene can lead to severe reactions to fluoropyrimidine-based chemotherapy. This test screens for those changes to help guide dosing and drug choice, supporting safer, more effective treatment decisions.
- Germline test (peripheral blood or saliva)
- Screens for significant variants in the DPYD gene
- Currently covers 13 of 28 known changes, with more in development
- Identifies risk of adverse reactions to fluoropyrimidine chemotherapy
- Supports dosing and drug-choice decisions to improve patient outcomes
Be the first to review “DPYD Test”
Related products
Familial mutation
R1 400
Microbiome test
R5 900
Nutrigenomics Standard
R3 900
PGx Static
R5 900
Whole genome sequencing
R15 500
Nutrigenomics Premier
R6 850
PGx Live
R7 500
Reviews
There are no reviews yet.